Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.